Oculus Innovative Sciences, Inc. announced that effective March 26, 2014, Hojabr Alimi and Richard Conley each tendered his resignation as a member of board of directors and his respective committee appointments. On March 26, 2014, board of directors appointed Sharon Barbari as a director of company. Ms. Barbari was also appointed as chairperson of Audit Committee, and as a member of Nominating and Corporate Governance Committee.

Ms. Barbari has served as Executive Vice President - Finance and Chief Financial Officer, of Cytokinetics Inc. since July 2009. The independent members of board have appointed Jerry McLaughlin to serve as lead independent director of board of directors, effective March 26, 2014. Mr. McLaughlin has served as a member of board of Directors since March 2013.